Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,614 | 24,825 | 11,245 | 11,346 | 8,116 |
| Receivables | 4,489 | 4,112 | 2,970 | 1,649 | 11,697 |
| Other current assets | 0 | 0 | 0 | 0 | 209 |
| TOTAL | $29,371 | $29,283 | $14,775 | $13,732 | $20,755 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 2 | 1 |
| Intangibles | 16 | 16 | 16 | 17 | 17 |
| TOTAL | $16 | $16 | $16 | $19 | $18 |
| Total Assets | $29,386 | $29,299 | $14,791 | $13,751 | $20,773 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,131 | 2,118 | 2,930 | 4,943 | 4,565 |
| Accrued Expenses | 1,084 | 948 | 643 | 436 | 714 |
| Other current liabilities | 5,400 | N/A | N/A | N/A | N/A |
| TOTAL | $9,827 | $3,726 | $4,333 | $5,656 | $5,657 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,212 | 660 | 760 | 277 | 379 |
| Other Non-Current Liabilities | 2,700 | 0 | 0 | 0 | 0 |
| TOTAL | $2,700 | $402 | $2,083 | $2,164 | $2,116 |
| Total Liabilities | $12,527 | $4,128 | $6,416 | $7,820 | $7,773 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,925 | 3,835 | 2,823 | 2,697 | N/A |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -74,421 | -64,883 | -63,966 | -62,569 | -53,225 |
| TOTAL | $16,859 | $25,171 | $8,375 | $5,931 | $13,000 |
| Total Liabilities And Equity | $29,386 | $29,299 | $14,791 | $13,751 | $20,773 |